ANDA 62008, held by Lilly. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 62008 (Nebcin), held by Lilly, was first approved by FDA on Oct 1, 1976, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 1, 1976 | Original application | Approved | None posted |
| NebcinEQ 40MG BASE/ML · injectable;injection | Tobramycin Sulfate | Discontinued |
| NebcinEQ 10MG BASE/ML · injectable;injection | Tobramycin Sulfate | Discontinued |
| Jun 18, 1992 | Supplement 16Labeling | Approved | None posted |
| Apr 10, 1990 | Supplement 11Labeling | Approved | None posted |
| Oct 1, 1976 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters